Navigation Links
Understanding The Predictors Of Prostate Cancer

A new study could change the way doctors treat certain prostate cancer patients.The three strongest predictors for the outcome for a prostate cancer patient are grade, PSA level and pathologic stage. //The summation of these three predictors is what determines the Gleason grading system or a Gleason score (GS). The most common Gleason score among patients with prostate cancer is seven. In a new study, researchers look to understand the prognosis of patients with a score of seven.

Researchers studied 412 patients with tumors that measured a Gleason score of seven and were treated with radical prostatectomy. They looked at the patient outcomes based on their Gleason pattern (GP). Different Gleason patterns of the tumor also help determine the Gleason score.

In the study group, researchers say 307 patients had primary GP three tumors, 105 patients had primary GP four tumors, and 17 had GP five tumors. Researchers found those with GP five had significantly shorter times to disease recurrence. Researchers also say patients with GP four and GP five had a higher risk for disease recurrence.

Researchers thus conclude when looking at Gleason scores of seven, those patients with GP four tumors are at risk for a more aggressive cancer. They say looking at the primary GP is easily accessible and clinically relevant predictor of disease recurrence in patients with GS seven prostate cancer. They hope this will help doctors in the management of patients with GS seven prostate cancer.


'"/>




Page: 1

Related medicine news :

1. Understanding Restless Legs Syndrome
2. Understanding Lung Cancer Metastasis
3. Understanding The Link Between Hormone Replacement and Respiratory Disease
4. Understanding The Risks Of Hormone Therapy
5. Understanding The Link Between Metabolic Syndrome And Drinking Patterns
6. A Better Understanding Of The Brain Network
7. Understanding The Predictor’s Of Alzheimer’s Diseae
8. Understanding The Harmful Effects Of Radiation Exposure
9. Understanding The Origin Of Tumors
10. Understanding Insulin Resistance
11. Understanding The Link Between Phobias And Fatal Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2017)... , ... June 26, 2017 , ... Antoine Dental Center is now offering ... in tooth replacement and act as a support for prosthetic teeth, such as crowns, bridges, ... existing bone and becomes a sturdy, lasting new root for the tooth. , Several ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... a recent review of government data released by the United Soybean Board. ... practices, Maryland’s soybean farmers have increased their productivity on less land per bushel, ...
(Date:6/26/2017)... TX (PRWEB) , ... June 26, 2017 , ... ... their coding staff, and consumers are seeing lots of red these days. According ... contain inaccurate charges that result from medical coding errors(1). Some studies point to ...
(Date:6/25/2017)... ... June 25, 2017 , ... FCPX LUT Vintage Volume 2 for Final Cut ... LUT Vintage Volume 2 contains 60 different color-grade presets, giving editors multiple options for ... blurs to single out subjects, plus much more. FCPX LUT Vintage Volume 2 is ...
(Date:6/25/2017)... , ... June 25, 2017 , ... An increase in ... growing foliage and plants, and along with that; a humdinger of an allergy season. ... it also means an increase in misery-causing grass and weed pollen. , “Our ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/5/2017)... 5, 2017 The Cincinnati ... Pharmacy, Inc. (NYSE: DPLO), has been awarded a Top ... Results are based on an employee survey administered ... and workplace improvement. The survey measures several aspects of workplace ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: